Payer & Market Access Expert — Gross-to-Net & Formulary Strategy
Mercor
| Company | Mercor |
| Category | Consulting & Strategy |
| Location | Remote — US-based or deep US-market experience |
| Remote | Remote (inferred) |
| Employment | Not stated |
| Level | Senior |
| Salary | USD 175–200 |
| Posted | 5 Aug 2026 |
| Last verified | 12 Aug 2026 |
| Source | The employer's own careers page (company_site) |
Description
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.
Responsibilities
• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
• Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
• Apply this across the pilot's set of drugs and drug classes
Requirements
• US-based payer / market access professional
• Familiarity with biotech/pharma development programs
• Hands-on with gross-to-net, rebates, and formulary tiering by drug class
• 5+ years in market access, pricing & reimbursement, or managed markets
Engagement Details
• Duration: Approximately 10–20 hours over a 1–2 week pilot
• Remote — US-based
Why Participate
• Help improve expert AI evaluation of drugs and drug-development programs
• Recurring engagement for strong contributors